Sign In
Buy ATR
$112.53
+0.350 (+0.312%)
At Close: Jun 03, 2026
5 Containers - Paper and Packaging Stocks to Watch in a Promising Industry
01:00pm, Monday, 27'th Oct 2025
E-commerce and consumer demand will drive the Zacks Containers-Paper & Packaging industry. Stocks like BXBLY, PKG, ATR, SEE and KRT are positioned for growth.
VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentati
AptarGroup (ATR) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Thursday, 23'rd Oct 2025
AptarGroup (ATR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Envestnet Portfolio Solutions Inc. Trims Holdings in AptarGroup, Inc. $ATR
04:40am, Thursday, 23'rd Oct 2025
Envestnet Portfolio Solutions Inc. decreased its position in AptarGroup, Inc. (NYSE: ATR) by 11.6% during the second quarter, according to the company in its most recent filing with the Securities and
Sequoia Financial Advisors LLC Invests $390,000 in AptarGroup, Inc. $ATR
03:42am, Wednesday, 22'nd Oct 2025
Sequoia Financial Advisors LLC purchased a new position in AptarGroup, Inc. (NYSE: ATR) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. T
Will AptarGroup (ATR) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Tuesday, 21'st Oct 2025
AptarGroup (ATR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV, FSE: 7JO0), a biopharmaceutical company advancing cancer th
CytoSorbents Provides DrugSorb-ATR Regulatory Update
07:00am, Tuesday, 16'th Sep 2025
PRINCETON, N.J. , Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery usi
AptarGroup, Inc. (ATR) 2025 Investor Day Call (Transcript)
02:43pm, Wednesday, 10'th Sep 2025
AptarGroup, Inc. (NYSE:ATR ) 2025 Investor Day Call Company Participants Marry Skafidas - Senior Vice President of Investor Relations & Communications Stephan Tanda - President, CEO & Executive Direct
AptarGroup Rewards Shareholders With 7% Hike in Quarterly Dividend
01:31pm, Tuesday, 09'th Sep 2025
ATR lifts its quarterly dividend by 7%, marking the 32nd straight year of increases for shareholders.
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength
05:00pm, Monday, 08'th Sep 2025
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength.
Aptar Announces 2025 Investor Day
05:00pm, Thursday, 04'th Sep 2025
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces 2025 Investor Day.
CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
07:00am, Wednesday, 20'th Aug 2025
FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization PRINCETON, N.J. , Aug. 20, 2025 /PRNew
AptarGroup (ATR) Q2 Revenue Rises 6%
03:34pm, Friday, 01'st Aug 2025
AptarGroup (ATR) Q2 Revenue Rises 6%
AptarGroup, Inc. (ATR) Q2 2025 Earnings Call Transcript
03:00pm, Friday, 01'st Aug 2025
AptarGroup, Inc. (NYSE:ATR ) Q2 2025 Earnings Conference Call August 1, 2025 9:00 AM ET Company Participants Mary Skafidas - Senior Vice President of Investor Relations & Communications Stephan B. Tan
